PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial- like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 1, 1998, Pages 11-18

  Van Giezen, J J J ^a   Nerme, V ^b   Abrahamsson, T ^b  

^a ASTRAZENECA   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Arterial thrombi; Fibrinolysis; In vitro; PAI 1 inhibition; Platelets

Indexed keywords

ALTEPLASE; PLASMINOGEN ACTIVATOR INHIBITOR;

ANIMAL EXPERIMENT; ARTERY THROMBOSIS; ARTICLE; DRUG EFFECT; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031918536     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199801000-00002     Document Type: Article

References (23)

1. Coller B. Platelets and thrombolytic therapy. N Engl J Med 1990; 22: 33-42.
2. Parise P, Agnelli G. Thrombus resistance to lysis and reocclusion after thrombolysis: the role of platelets. Blood Coag Fibrinol 1991; 2: 749-758.
3. Kruithof EKO, Tran-Thang C, Bachmann F. Studies on the release of plasminogen activator inhibitor from human platelets. Thromb Haemost 1986; 55: 201-205.
4. Erickson LA, Ginsberg MH, Loskutoff DJ. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984; 74: 1465-1472.
5. Torr-Brown SR, Sobel BE. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets. Thromb Res 1993; 72: 413-421.
6. Potter van Loon BJ, Rijken DC, Brommer EJP, van der Maas APC. The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysability. Thromb Haemost 1992; 67: 101-105.
7. Robbie LA, Bennet B, Croll AM, Brown PAJ, Booth NA. Proteins of the fibrinolytic system in human thrombi. Thromb Haemost 1996; 75: 127-133.
8. Booth NA, Simpson AJ, Croll A, Bennet B, Mac-Gregor IR. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 1988; 70: 327-333.
9. Reilly CF, Hutzlmann JE. Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator mediated fibrinolysis. J Biol Chem 1992; 267: 17128-17135.
10. Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes mediated by both the finger and the kringle-2 domain of t-PA. J Clin Invest 1989; 84: 647-655.
11. Chandler AB. In vitro thrombotic coagulation of the blood. A method for producing a thrombus. Lab Invest 1958; 7: 110-114.
12. Stringer HAR, van Swieten P, Heijnen MFG, Sixma JJ, Pannekoek H. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop. Arterioscler Thromb 1994; 14: 1452-1458.
13. Robbie LA, Young SP, Bennett B, Booth NA. Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and PAI-1 content and distribution. Thromb Haemost 1997; 77: 510-515.
14. Abrahamsson T, Björquist P, Deinum J, Ehnebom J, Hulander M, Legnehed A, et al. An antibody fragment against PAI-1 inhibits PAI-1 activity and stimulates fibrinolysis in vitro and in vivo. Fibrinolysis 1994; 8(Suppl 2): 55-56.
15. Abrahamsson T, Nerme V, Strömqvist M, Åkerblom B, Legnehed A, Pettersson K, et al. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin. Thromb Haemost 1996; 75: 118-126.
16. ab-fragment of a PAI-1 inhibiting antibody reduces thrombus sizc and restores blood flow in a rat model of arterial thrombosis. Thromb Haemost 1997; 77: 964-969.
17. Verheijen JH, Mullaart E, Chang GTC, Kluft C. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurement in plasma. Thromb Haemost 1982; 48: 266-269.
18. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost 1984; 51: 392-395.
19. Clemmensen I. Three new E-antigenic fibrinogen fractions found in an commercial plasmin preparation. Science tools, LBK Instr J 1973; 20: 7-8.
20. Lindahl TL, Sigurdardottir O, Wiman B. Stability of plasminogen activator inhibitor 1 (PAI-1). Thromb Haemost 1989; 62: 748-751.
21. Emeis JJ, van den Hoogen CM. Pharmacological modulation of the endotoxin-induced increase in plasminogen activator inhibitor activity in rats. Blood Coag Fibrinol 1992; 3: 575-581.
22. Kluft C, Jie AFH, Sprengers ED, Verheijen JH. Identification of a reversible inhibitor of plasminogen activators in blood plasma. FEBS Lett 1985; 190: 315-318.
23. Emeis JJ, van Houwelingen AC, van den Hoogen CM, Hornstra G. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood 1989; 74: 233-237.